Rhoads Ann D's Form 4 filing
Globus Medical Inc (GMED) · filed Nov 10, 2025
- Accession no.
- 0001193125-25-274288
- Filed
- Nov 10, 2025
- Trade date
- Nov 7-10, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $818.0K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rhoads Ann DCIK 0001250252 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2025 | Class A Common Stock | SSaleDisposed | −8,000 | $81.00 | −$648,000 | 17,384 | Direct | |
| Nov 10, 2025 | Class A Common Stock | SSaleDisposed | −2,000 | $85.00 | −$170,000 | 15,384 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.